Frequent Use of Premenopausal Progestin in Women With Prior Preeclampsia
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae677 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Johanna M Joensuu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki FI-00290, Finland. Hauptthemen laut MEDLINE: Progestins, Pre-Eclampsia, Premenopause, Intrauterine Devices, Medicated. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helsinki University Hospital, Finnish Academy of Sciences.
Abstract (Originalsprache)
Context
Women with a history of preeclamptic pregnancy are predisposed to later occlusive vascular diseases.
Objective
We compared the use of cyclic progestins or levonorgestrel-releasing intrauterine device (LNG-IUD) for treatment of menstrual cycle abnormalities between premenopausal women with and without a prior preeclamptic pregnancy.
Methods
Register-based cohort study during 1994 to 2019 of oral progestin or LNG-IUD in Finnish women with (n = 31 688) and without (n = 91 726) prior preeclampsia in 1969 to 1993. Cyclic progestin or LNG-IUD use and its association with future use of menopausal hormone therapy (MHT).
Results
Women with prior preeclampsia had used cyclic progestins more often (23.5% vs 9.1%; P < .001) and initiated the use at younger ages (41.8 years, SD 6.3 vs 45.9 years, 3.1; P < .001) than control women. Also, LNG-IUD was inserted more frequently (P < .001) in women with prior preeclampsia (9.3%) than in controls (4.7%). Cyclic progestin or LNG-IUD use was accompanied by significant 37% to 90% elevations in future MHT use.
Conclusion
Increased use of cyclic progestins and LNG-IUD in premenopausal women with a history of preeclamptic pregnancy can be seen as indirect evidence of earlier onset of ovulatory dysfunction. This may contribute to the elevated risk of endometrial cancer in these women. Our findings may indicate an additional late sequela of preeclamptic pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki FI-00290, Finland.
- Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki FI-00271, Finland.
- Academic Primary Health Care Centre, Region Stockholm, Stockholm 45436, Sweden.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm 17177, Sweden.
ORCID-Profile: Johanna M Joensuu, Olavi Ylikorkala, Minttu Venetkoski, Mika Gissler, Hanna Savolainen-Peltonen, Tomi S Mikkola
Förderung
- Helsinki University Hospital
- Finnish Academy of Sciences
Zitieren
APA
Joensuu, J. M., Ylikorkala, O., Venetkoski, M., Gissler, M., Savolainen-Peltonen, H., & Mikkola, T. S. (2025). Frequent Use of Premenopausal Progestin in Women With Prior Preeclampsia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae677
Vancouver
Joensuu JM, Ylikorkala O, Venetkoski M, Gissler M, Savolainen-Peltonen H, Mikkola TS. Frequent Use of Premenopausal Progestin in Women With Prior Preeclampsia. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae677
BibTeX
@article{Joensuu2025,
author = {Joensuu, Johanna M and Ylikorkala, Olavi and Venetkoski, Minttu and Gissler, Mika and Savolainen-Peltonen, Hanna and Mikkola, Tomi S},
title = {Frequent Use of Premenopausal Progestin in Women With Prior Preeclampsia},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae677}
}
EUVIMED